4.8 Article

SCAF4 and SCAF8, mRNA Anti-Terminator Proteins

Journal

CELL
Volume 177, Issue 7, Pages 1797-+

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2019.04.038

Keywords

-

Funding

  1. Francis Crick Institute (FCI from Cancer Research UK) [FC001166]
  2. Francis Crick Institute (FCI from Medical Research Council) [FC001166]
  3. Francis Crick Institute (FCI from Wellcome Trust) [FC001166]
  4. European Research Council [693327]
  5. EMBO-LTF program [EMBO ALTF 1026-2014]
  6. Human Frontier Science Program [LT000640/2013]

Ask authors/readers for more resources

Accurate regulation of mRNA termination is required for correct gene expression. Here, we describe a role for SCAF4 and SCAF8 as anti-terminators, suppressing the use of early, alternative polyadenylation (polyA) sites. The SCAF4/8 proteins bind the hyper-phosphorylated RNAPII C-terminal repeat domain (CTD) phosphorylated on both Ser2 and Ser5 and are detected at early, alternative polyA sites. Concomitant knockout of human SCAF4 and SCAF8 results in altered polyA selection and subsequent early termination, leading to expression of truncated mRNAs and proteins lacking functional domains and is cell lethal. While SCAF4 and SCAF8 work redundantly to suppress early mRNA termination, they also have independent, non-essential functions. SCAF8 is an RNAPII elongation factor, whereas SCAF4 is required for correct termination at canonical, distal transcription termination sites in the presence of SCAF8. Together, SCAF4 and SCAF8 coordinate the transition between elongation and termination, ensuring correct polyA site selection and RNAPII transcriptional termination in human cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available